Evinacumab Approval Adds a New Option for Homozygous Familial Hypercholesterolemia With a Hefty Price Tag.

Published on Jun 22, 2021in Circulation23.603
· DOI :10.1161/CIRCULATIONAHA.121.055463
Bridget M. Kuehn6
Estimated H-index: 6
Sources
Abstract
References0
Newest
Cited By0
Newest
#1Chih-Kuo Lee (NTU: National Taiwan University)
#2Che-Wei Liao (NTU: National Taiwan University)
Last. Ming-Shiang Wu (NTU: National Taiwan University)
view all 6 authors...
Despite advances in pharmacotherapy, intervention devices and techniques, residual cardiovascular risks still cause a large burden on public health. Whilst most guidelines encourage achieving target levels of specific lipids and lipoproteins to reduce these risks, increasing evidence has shown that molecular modification of these lipoproteins also has a critical impact on their atherogenicity. Modification of low-density lipoprotein (LDL) by oxidation, glycation, peroxidation, apolipoprotein C-I...
Source